Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-22
DOI
10.3389/fonc.2022.820968
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From 1901 to 2022, how far are we from truly understanding the pathogenesis of age-related dementia?
- (2022) Xing Fang et al. GeroScience
- Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review
- (2022) Shuwen Ge et al. Frontiers in Oncology
- The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
- (2021) Narasimha M. Beeraka et al. Cancers
- Novel Mechanistic Insights and Potential Therapeutic Impact of TRPC6 in Neurovascular Coupling and Ischemic Stroke
- (2021) Shashank Shekhar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histomorphological and Functional Features of the Eutopic Endometrium in Patients with Ovarian Endometriosis After Surgery—a Clinical Study
- (2021) Liudmila M. Mikhaleva et al. Reproductive Sciences
- Recent Insights into the Nutritional Antioxidant Therapy in Prevention and Treatment of Diabetic Vascular Complications - A comprehensive Review
- (2021) Narasimha M. Beeraka et al. CURRENT MEDICINAL CHEMISTRY
- The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status
- (2021) Gjumrakch Aliev et al. CURRENT MEDICINAL CHEMISTRY
- Totally Implantable Venous Access Port Systems: Implant Depth-based Complications in Breast Cancer Therapy - A Comparative Study
- (2021) Kuo Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Anterior Abdominal Wall Defect Closed by the Anterior Sheath of the Upper Rectus Abdominis Muscle in a Patient with Prior “TRAM Flap Breast Reconstruction”
- (2021) Kuo Chen et al. Indian Journal of Surgery
- Efficacy of da Vinci robot‐assisted lymph node surgery than conventional axillary lymph node dissection in breast cancer – A comparative study
- (2021) Kuo Chen et al. International Journal of Medical Robotics and Computer Assisted Surgery
- Effect of the Intake of Isoflavones on Risk Factors of Breast Cancer—A Systematic Review of Randomized Controlled Intervention Studies
- (2021) Luisa Finkeldey et al. Nutrients
- Correction: Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: Involvement of p53/FoxO3A axis
- (2020) Saroj Nepal et al. Oncotarget
- Therapeutic Potential of Mesenchymal Stem Cells for Postmastectomy Lymphedema: A Literature Review
- (2020) Kuo Chen et al. CTS-Clinical and Translational Science
- The Role of Exosomes in Stemness and Neurodegenerative Diseases—Chemoresistant-Cancer Therapeutics and Phytochemicals
- (2020) Narasimha M. Beeraka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers
- (2020) Kuo Chen et al. SEMINARS IN CANCER BIOLOGY
- Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study
- (2020) Irina R. Gilyazova et al. CURRENT CANCER DRUG TARGETS
- An Overview on Targeting Legumain for Inhibiting Cancers.
- (2020) Bandi Deepa Reddy et al. CURRENT PHARMACEUTICAL DESIGN
- A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
- (2019) Alessio Cortellini et al. Journal for ImmunoTherapy of Cancer
- Germline mutation status and therapy response in high-risk early breast cancer: Results of the GeparOcto study (NCT02125344).
- (2019) Esther Pohl-Rescigno et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade
- (2019) Aleix Prat et al. JNCI-Journal of the National Cancer Institute
- Neferine and isoliensinine from Nelumbo nucifera induced reactive oxygen species (ROS)-mediated apoptosis in colorectal cancer HCT-15 cells
- (2019) Manogaran Prasath et al. African Journal of Pharmacy and Pharmacology
- Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase
- (2019) Jeonghun Han et al. Journal of Oncology
- Obesity and Breast Cancer: Role of Leptin
- (2019) Flora Sánchez-Jiménez et al. Frontiers in Oncology
- The cytoprotective and anti-cancer potential of bisbenzylisoquinoline alkaloids from Nelumbo nucifera.
- (2019) Prasath Manogaran et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Neferine and isoliensinine enhance ‘intracellular uptake of cisplatin’ and induce ‘ROS-mediated apoptosis’ in colorectal cancer cells – A comparative study
- (2019) Prasath Manogaran et al. FOOD AND CHEMICAL TOXICOLOGY
- nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
- (2018) D A Yardley et al. ANNALS OF ONCOLOGY
- The Obesity Paradox in Cancer: How Important Is Muscle?
- (2018) Elizabeth M. Cespedes Feliciano et al. Annual Review of Nutrition
- The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC)
- (2018) Tao Lianyuan et al. CANCER BIOLOGY & THERAPY
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- Hormone receptor–positive, HER2-negative metastatic breast cancer: redrawing the lines
- (2018) A. Matutino et al. Current Oncology
- Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
- (2018) Sibylle Loibl et al. LANCET ONCOLOGY
- Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
- (2018) Jennifer L McQuade et al. LANCET ONCOLOGY
- Leptin Signaling Mediates Obesity-Associated CSC Enrichment and EMT in Preclinical TNBC Models
- (2018) Laura W. Bowers et al. MOLECULAR CANCER RESEARCH
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors
- (2018) Marian L Neuhouser et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Standard Neoadjuvant Treatment in Early/Locally Advanced Breast Cancer
- (2018) Cristina Pernaut et al. Breast Care
- Histone deacetylase 6 regulated expression of IL-8 is involved in the doxorubicin (Dox) resistance of osteosarcoma cells via modulating ABCB1 transcription
- (2018) Mo Cheng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The epidemiology of obesity
- (2018) Yu Chung Chooi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial
- (2018) Andreas Schneeweiss et al. EUROPEAN JOURNAL OF CANCER
- Crosstalk between Estrogen Signaling and Breast Cancer Metabolism
- (2018) Eylem Kulkoyluoglu-Cotul et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance
- (2017) Praveena S Thiagarajan et al. ENDOCRINE-RELATED CANCER
- Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity–breast cancer link
- (2017) H Zahid et al. INTERNATIONAL JOURNAL OF OBESITY
- Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes
- (2017) Shenying Fang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- NCCN Guidelines Insights: Breast Cancer, Version 1.2017
- (2017) William J. Gradishar et al. Journal of the National Comprehensive Cancer Network
- Leptin induces ROS via NOX5 in healthy and neoplastic mammary epithelial cells
- (2017) Sinda Mahbouli et al. ONCOLOGY REPORTS
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2
- (2017) Yunxiu Huang et al. CELLULAR ONCOLOGY
- APC loss in breast cancer leads to doxorubicin resistance via STAT3 activation
- (2017) Monica K. VanKlompenberg et al. Oncotarget
- A multi-institutional double-blind phase II study evaluating response and surrogate biomarkers to carboplatin and nab-paclitaxel (CP) with or without vorinostat as preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer (TBCRC008).
- (2017) R. M. Connolly et al. JOURNAL OF CLINICAL ONCOLOGY
- Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer
- (2016) Laura E. G. Warren et al. ANNALS OF SURGICAL ONCOLOGY
- Leptin, obesity and breast cancer: progress to understanding the molecular connections
- (2016) Ines Barone et al. CURRENT OPINION IN PHARMACOLOGY
- Inflammation, dysregulated metabolism and aromatase in obesity and breast cancer
- (2016) Heba Zahid et al. CURRENT OPINION IN PHARMACOLOGY
- Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion
- (2016) KUANGFA LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sirtuins in metabolism, DNA repair and cancer
- (2016) Zhen Mei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
- (2016) Michael Untch et al. LANCET ONCOLOGY
- The Obesity Paradox in Cancer: a Review
- (2016) Hannah Lennon et al. Current Oncology Reports
- Time to Surgery and Breast Cancer Survival in the United States
- (2016) Richard J. Bleicher et al. JAMA Oncology
- Progress in adjuvant chemotherapy for breast cancer: an overview
- (2015) Jesus Anampa et al. BMC Medicine
- Overall and central adiposity and breast cancer risk in the sister study
- (2015) Alexandra J. White et al. CANCER
- Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
- (2015) Michael D. Brooks et al. Cell Stem Cell
- Chronic-Leptin Attenuates Cisplatin Cytotoxicity in MCF-7 Breast Cancer Cell Line
- (2015) Mercedes Nadal-Serrano et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Therapies for triple negative breast cancer
- (2015) Eleni Andreopoulou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
- (2015) William M. Sikov et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer
- (2015) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial
- (2015) Helena M Earl et al. LANCET ONCOLOGY
- Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy
- (2015) Jian Zhang et al. Oncotarget
- Female Breast Cancer and Alcohol Consumption
- (2014) Chiara Scoccianti et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Obesity and cancer pathogenesis
- (2014) Nathan A. Berger Annals of the New York Academy of Sciences
- Influence of Lifestyle Factors on Breast Cancer Risk
- (2014) Max Dieterich et al. Breast Care
- Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
- (2014) T Yoshida et al. BRITISH JOURNAL OF CANCER
- Nutrition and Physical Activity Cancer Prevention Guidelines, Cancer Risk, and Mortality in the Women's Health Initiative
- (2014) C. A. Thomson et al. Cancer Prevention Research
- Increased Adipocyte O2 Consumption Triggers HIF-1α, Causing Inflammation and Insulin Resistance in Obesity
- (2014) Yun Sok Lee et al. CELL
- 20 YEARS OF LEPTIN: Connecting leptin signaling to biological function
- (2014) Margaret B Allison et al. JOURNAL OF ENDOCRINOLOGY
- Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
- (2013) B. Gerber et al. ANNALS OF ONCOLOGY
- Night-shift work and risk of breast cancer: a systematic review and meta-analysis
- (2013) Biren B. Kamdar et al. BREAST CANCER RESEARCH AND TREATMENT
- The association between different night shiftwork factors and breast cancer: a case–control study
- (2013) L Fritschi et al. BRITISH JOURNAL OF CANCER
- Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2
- (2013) Kathleen I. Pritchard et al. Clinical Breast Cancer
- Molecular Pathways: How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors?
- (2013) Peter Bouwman et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Long-term Drug Treatment for Obesity
- (2013) Susan Z. Yanovski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
- (2013) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin and IGFs in Obesity-Related Breast Cancer
- (2013) Valentina Belardi et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Does obesity have an effect on outcomes in triple-negative breast cancer?
- (2013) Ronny Mowad et al. JOURNAL OF SURGICAL RESEARCH
- Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors
- (2013) N. Travier et al. MEDICAL ONCOLOGY
- CREB-Regulated Transcription Co-Activator Family Stimulates Promoter II-Driven Aromatase Expression in Preadipocytes
- (2013) Nirukshi U. Samarajeewa et al. Hormones & Cancer
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- The current state of breast cancer classification
- (2012) G. Viale ANNALS OF ONCOLOGY
- Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies
- (2012) D. Aune et al. ANNALS OF ONCOLOGY
- Nutrition and physical activity guidelines for cancer survivors
- (2012) Cheryl L. Rock et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Leptin Mediates Tumor-Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells
- (2012) I. Barone et al. CANCER RESEARCH
- Impact of Body Mass Index on Survival Outcome Among Women With Early Stage Triple-Negative Breast Cancer
- (2012) Shaheenah Dawood et al. Clinical Breast Cancer
- Molecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance
- (2012) K. G. Chen et al. CLINICAL CANCER RESEARCH
- Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models
- (2012) P. J. Roberts et al. CLINICAL CANCER RESEARCH
- Quantifying insulin receptor isoform expression in FFPE breast tumors
- (2012) Sean C. Harrington et al. GROWTH HORMONE & IGF RESEARCH
- Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
- (2012) Cynthia X. Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast Cancer
- (2012) Elizabeth J. Folkerd et al. JOURNAL OF CLINICAL ONCOLOGY
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657
- (2012) Laura J. Esserman et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine-related cancers and the role of AMPK
- (2012) Kristy A. Brown et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
- (2012) Justin M Balko et al. NATURE MEDICINE
- Weight loss reduces breast ductal fluid estrogens in obese postmenopausal women: a single arm intervention pilot study
- (2012) Catherine L Carpenter et al. Nutrition Journal
- First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study
- (2012) Christoph Thomssen et al. ONCOLOGY
- Insulin Receptor Isoforms A and B as well as Insulin Receptor Substrates-1 and -2 Are Differentially Expressed in Prostate Cancer
- (2012) Martin Heni et al. PLoS One
- Natrelle Style 410 Form-Stable Silicone Breast Implants: Core Study Results at 6 Years
- (2012) G. Patrick Maxwell et al. Aesthetic Surgery Journal
- Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project
- (2011) Marilyn L. Kwan et al. BREAST CANCER RESEARCH AND TREATMENT
- Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies
- (2011) Jia-Yi Dong et al. BREAST CANCER RESEARCH AND TREATMENT
- Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer
- (2011) Rulla M. Tamimi et al. BREAST CANCER RESEARCH AND TREATMENT
- The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
- (2011) Mieke Kriege et al. CANCER
- Microbiome and Malignancy
- (2011) Claudia S. Plottel et al. Cell Host & Microbe
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance
- (2011) Rabab A A Mohammed et al. MODERN PATHOLOGY
- Aromatase, breast cancer and obesity: a complex interaction
- (2011) Serdar E. Bulun et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Effects of a short-term differently dosed aerobic exercise on maximum aerobic capacity in breast cancer survivors: A pilot study
- (2011) Zorica Brdareski et al. Vojnosanitetski Pregled
- Mitochondrial dysfunction in obesity
- (2011) Juan C Bournat et al. Current Opinion in Endocrinology Diabetes and Obesity
- Targeting of renal proximal tubule Na,K-ATPase by salt-inducible kinase
- (2010) Mary Taub et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
- (2010) Melinda Protani et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular mechanisms of leptin and adiponectin in breast cancer
- (2010) Thierry Jardé et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells
- (2010) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Energy Balance, Host-Related Factors, and Cancer Progression
- (2010) Stephen D. Hursting et al. JOURNAL OF CLINICAL ONCOLOGY
- Bariatric surgery: Mechanisms, indications and outcomes
- (2010) Paul E O'Brien JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Physical activity, diet, adiposity and female breast cancer prognosis: A review of the epidemiologic literature
- (2010) Ruth E. Patterson et al. MATURITAS
- American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
- (2010) Kathryn H. Schmitz et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
- (2010) Daniel J. Toft et al. MOLECULAR ENDOCRINOLOGY
- Safety and Effectiveness of Mentor’s MemoryGel Implants at 6 Years
- (2009) Bruce Cunningham et al. AESTHETIC PLASTIC SURGERY
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Triple-negative breast cancer--current status and future directions
- (2009) O. Gluz et al. ANNALS OF ONCOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
- (2009) Miguel Martín et al. BREAST CANCER RESEARCH AND TREATMENT
- Obesity is a Risk Factor for Developing Postoperative Lymphedema in Breast Cancer Patients
- (2009) Lucy K. Helyer et al. Breast Journal
- The epidemiology of triple-negative breast cancer, including race
- (2009) Katrina F. Trivers et al. CANCER CAUSES & CONTROL
- Defective Repair of Oxidative DNA Damage in Triple-Negative Breast Cancer Confers Sensitivity to Inhibition of Poly(ADP-Ribose) Polymerase
- (2009) E. Alli et al. CANCER RESEARCH
- Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
- (2009) O. K. Mirzoeva et al. CANCER RESEARCH
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
- (2009) K. P. Hoeflich et al. CLINICAL CANCER RESEARCH
- HER-2 Signaling and Inhibition in Breast Cancer
- (2009) B. Browne et al. CURRENT CANCER DRUG TARGETS
- Exemestane
- (2009) Emma D. Deeks et al. DRUGS
- Restoring Endocrine Response in Breast Cancer Cells by Inhibition of the Sphingosine Kinase-1 Signaling Pathway
- (2009) Olga Sukocheva et al. ENDOCRINOLOGY
- Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer
- (2009) Xavier B. Pivot et al. EUROPEAN JOURNAL OF CANCER
- Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer inBRCA1andBRCA2Mutation Carriers
- (2009) Mieke Kriege et al. JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic Review
- (2008) Christine M. Velicer et al. JOURNAL OF CLINICAL ONCOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Dietary Patterns and Breast Cancer Recurrence and Survival Among Women With Early-Stage Breast Cancer
- (2008) Marilyn L. Kwan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
- (2008) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Refinement of breast cancer classification by molecular characterization of histological special types
- (2008) B Weigelt et al. JOURNAL OF PATHOLOGY
- Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer
- (2008) Rowan T. Chlebowski et al. JNCI-Journal of the National Cancer Institute
- Chronodisruption and cancer
- (2008) Thomas C. Erren et al. NATURWISSENSCHAFTEN
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- (2008) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
- (2007) Michele De Laurentiis et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
- (2007) Alessandra Gennari et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search